Contact
searchSearch
HMP Global

Advances in Inflammatory Bowel Disease Network

Featured

IBD Drive time logo
Expert Insights
IBD Drive Time: Adam Faye, MD, on Managing IBD in Special Populations
11/03/2026
Raymond Cross, MD; Adam Faye, MD, MS
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Drs Adam Faye and Raymond Cross...
11/03/2026
Advances in Inflammatory Bowel Disease Network
FDA Approval
FDA Approves SC Induction With Risankizumab in Crohn's Disease
11/03/2026
Rebecca Mashaw
The U.S. Food and Drug Administration has approved a subcutaneous induction regimen for risankizumab-rzaa for adults with moderately to severely active Crohn's disease.
The U.S. Food and Drug Administration has approved a subcutaneous induction regimen for risankizumab-rzaa for adults with moderately to severely active Crohn's disease.
The U.S. Food and Drug...
11/03/2026
Advances in Inflammatory Bowel Disease Network
Conference Coverage
IL-23 Inhibitors Show Clinical, Endoscopic Efficacy in Chronic Pouch Disorders
10/28/2026
Jessica Garlewicz
Prior biologic or anti-TNF exposure, pouch phenotype, and perianal fistulas did not influence clinical or endoscopic remission rates among patients with pouchitis treated with risankizumab.
Prior biologic or anti-TNF exposure, pouch phenotype, and perianal fistulas did not influence clinical or endoscopic remission rates among patients with pouchitis treated with risankizumab.
Prior biologic or anti-TNF...
10/28/2026
Advances in Inflammatory Bowel Disease Network
David Schwartz
Conference Coverage
David Schwartz, MD, on Perianal Crohn's Disease
10/28/2026
David A. Schwartz
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his...
10/28/2026
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Positioning Therapies and Improving Outcomes in Ulcerative Colitis
10/23/2026
David T. Rubin, MD
Dr Rubin presents the key takeaways from his lecture on positioning therapies for ulcerative colitis to optimize outcomes, which he delivered at the ACG Postgraduate Course in Nashville. 
Dr Rubin presents the key takeaways from his lecture on positioning therapies for ulcerative colitis to optimize outcomes, which he delivered at the ACG Postgraduate Course in Nashville. 
Dr Rubin presents the key...
10/23/2026
Advances in Inflammatory Bowel Disease Network
Nayantara Coelho-Prabhu
Conference Coverage
Nayantara Coelho-Prabhu, MD, on Dysplasia Detection in IBD and PSC-IBD
10/15/2026
Nayantara Coelho-Prabhu, MD
Dr Coelho-Prabhu reviews the timing and techiques for surveillance of patients with inflammatory bowel disease for signs of colorectal cancer--and especially those with IBD and primary sclerosing cholangitis, which places them among those...
Dr Coelho-Prabhu reviews the timing and techiques for surveillance of patients with inflammatory bowel disease for signs of colorectal cancer--and especially those with IBD and primary sclerosing cholangitis, which places them among those...
Dr Coelho-Prabhu reviews the...
10/15/2026
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Histologic Outcomes of QUASAR Extension Study
10/13/2026
David T. Rubin, MD
Dr Rubin reviews data from the QUASAR phase 3 trial of guselkumab in patients with ulcerative colitis, specifically looking at histologic remission, which he presented at the ACG Scientific Meeting in Nashville.
Dr Rubin reviews data from the QUASAR phase 3 trial of guselkumab in patients with ulcerative colitis, specifically looking at histologic remission, which he presented at the ACG Scientific Meeting in Nashville.
Dr Rubin reviews data from the...
10/13/2026
Advances in Inflammatory Bowel Disease Network
Ray Cross
Conference Coverage
Raymond Cross, MD, on Fibrostenotic Crohn's Disease
10/11/2026
Raymond Cross, MD
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Dr Cross reviews his...
10/11/2026
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Assisted Reproductive Technology Shows Pregnancy Success in Women With IBD
10/11/2026
Rebecca Mashaw
The WIsDoM prospective study is the first to examine assisted reproductive technology outcomes among women with IBD,
The WIsDoM prospective study is the first to examine assisted reproductive technology outcomes among women with IBD,
The WIsDoM prospective study is...
10/11/2026
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Early Surgery or IL-23 for Crohn's Disease? Drs Corey Siegel and Gil Melmed Discuss Patient Survey Results
10/11/2026
Corey A. Siegel, MD, MS; Gil Y. Melmed, MD
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed...
10/11/2026
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Inulin Reduces C diff Colonization in UC Microbiomes In Vitro
10/11/2026
Rebecca Mashaw
A study of Clostridioides difficile colonization in the microbiome of ulcerative colitis won an ACG Outstanding Research Award in the Infections and Microbiome Category at the American College of Gastroenterology Scientific Meeting.
A study of Clostridioides difficile colonization in the microbiome of ulcerative colitis won an ACG Outstanding Research Award in the Infections and Microbiome Category at the American College of Gastroenterology Scientific Meeting.
A study of Clostridioides...
10/11/2026
Advances in Inflammatory Bowel Disease Network

Advances in Inflammatory Bowel Diseases (AIBD)

Michael Kappelman
From the AIBD Open Air Studio
The Sherman Prize: Michael Kappelman, MD
12/29/2025
Michael Kappelman, MD
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the Sherman Prize winners for 2025, speaks from the Open Air Studio at the Advances in IBD meeting about his clinical and research work with pediatric patients with ulcerative colitis or Crohn's disease.
Dr Michael Kappelman, one of the...
12/29/2025
Advances in Inflammatory Bowel Disease Network
Corey & Miguel
From the AIBD Open Air Studio
Optimize or Switch Therapy? Siegel vs Regueiro Debate
12/23/2025
Miguel D. Regueiro, MD; Corey A. Siegel, MD, MS
For the 9th year, Drs Miguel Regueiro and Corey Siegel both claim victory in their annual debate—this time, about switching vs optimizing therapies—and remain friends.
For the 9th year, Drs Miguel Regueiro and Corey Siegel both claim victory in their annual debate—this time, about switching vs optimizing therapies—and remain friends.
For the 9th year, Drs Miguel...
12/23/2025
Advances in Inflammatory Bowel Disease Network
Ray Cross and Tina Ha
From the AIBD Open Air Studio
IBD Drive Time: Christina Ha, MD, on Positioning IBD Therapies
12/23/2025
Raymond Cross, MD; Christina Ha, MD
In the first-ever video version of the IBD Drive Time podcast, Drs Raymond Cross and Christina Ha discuss positioning IBD therapies from our Open Air Studio at the AIBD Annual Meeting.
In the first-ever video version of the IBD Drive Time podcast, Drs Raymond Cross and Christina Ha discuss positioning IBD therapies from our Open Air Studio at the AIBD Annual Meeting.
In the first-ever video version...
12/23/2025
Advances in Inflammatory Bowel Disease Network
JAKs panel AIBD 2025
From the AIBD Open Air Studio
Positioning JAK Inhibitors in IBD
12/22/2025
Corey A. Siegel, MD, MS; Gil Y. Melmed, MD; Adam S. Cheifetz, MD
Drs Corey Siegel, Gil Melmed, and Adam Cheifetz took to the Open Air Studio at the AIBD annual meeting to discuss an important recent change in FDA labeling for upadacitinib and the positioning of JAK inhibitors in the management of IBD.
Drs Corey Siegel, Gil Melmed, and Adam Cheifetz took to the Open Air Studio at the AIBD annual meeting to discuss an important recent change in FDA labeling for upadacitinib and the positioning of JAK inhibitors in the management of IBD.
Drs Corey Siegel, Gil Melmed,...
12/22/2025
Advances in Inflammatory Bowel Disease Network
Rubin & Hanauer
From the AIBD Open Air Studio
Learning From the Masters: David Rubin, MD, and Stephen Hanauer, MD
12/19/2025
David T. Rubin, MD; Stephen B. Hanauer, MD
     
     
     
12/19/2025
Advances in Inflammatory Bowel Disease Network
Remo Panaccione
Conference Coverage
Remo Panaccione, MD, on EIMs of the Nervous System in IBD
12/19/2025
Remo Panaccione
Dr Panaccione reviews his presentation at the Advances in IBD annual meeting on extraintestinal manifestations of the nervous system, including peripheral neuropathy, cerebral venous thrombosis, and demylenating disorders.
Dr Panaccione reviews his presentation at the Advances in IBD annual meeting on extraintestinal manifestations of the nervous system, including peripheral neuropathy, cerebral venous thrombosis, and demylenating disorders.
Dr Panaccione reviews his...
12/19/2025
Advances in Inflammatory Bowel Disease Network
Best of 2025
From the AIBD Open Air Studio
Best of 2025 in IBD: Expert Roundtable from Advances in IBD
12/18/2025
Marla C. Dubinsky, MD; Parambir Dulai, MD; Bruce E. Sands, MD, MS
Drs Marla Dubinsky, Bruce Sands, and Parambir Dulai inaugurated the Open Air Studio at the Advances in IBD 2025 annual meeting with a review of the best research and most promising advances in the treatment of inflammatory bowel disease...
Drs Marla Dubinsky, Bruce Sands, and Parambir Dulai inaugurated the Open Air Studio at the Advances in IBD 2025 annual meeting with a review of the best research and most promising advances in the treatment of inflammatory bowel disease...
Drs Marla Dubinsky, Bruce Sands,...
12/18/2025
Advances in Inflammatory Bowel Disease Network
Ray Cross
Conference Coverage
Raymond Cross, MD, on Risk Stratification and Individualized Treatment Selection in Evolving IBD Management
12/17/2025
Jessica Garlewicz
Dr Raymond Cross emphasized the importance of identifying risk early and aligning therapy with both clinical severity and patient-specific needs as IBD moves toward precision medicine.
Dr Raymond Cross emphasized the importance of identifying risk early and aligning therapy with both clinical severity and patient-specific needs as IBD moves toward precision medicine.
Dr Raymond Cross emphasized the...
12/17/2025
Advances in Inflammatory Bowel Disease Network
Millie Long
Conference Coverage
Millie Long, MD, on Understanding Infection Risk in IBD
12/17/2025
Jessica Garlewicz
Steroid reduction, risk stratification, and preventive strategies remain central, Dr Long said at the Advances in IBD annual meeting.
Steroid reduction, risk stratification, and preventive strategies remain central, Dr Long said at the Advances in IBD annual meeting.
Steroid reduction, risk...
12/17/2025
Advances in Inflammatory Bowel Disease Network
Amy Stewart
From the AIBD Open Air Studio
Amy Stewart, NP, on Advances in Subcutaneous IBD Therapy
12/17/2025
Amy Stewart, NP
Amy Stewart, NP, the results of a post-hoc analysis of data from the LIBERTY study in Crohn's disease for Zymfentra, a subcutaneous formulation of infliximab, and how it and other subcutaneous options provide important options for patients...
Amy Stewart, NP, the results of a post-hoc analysis of data from the LIBERTY study in Crohn's disease for Zymfentra, a subcutaneous formulation of infliximab, and how it and other subcutaneous options provide important options for patients...
Amy Stewart, NP, the results of...
12/17/2025
Advances in Inflammatory Bowel Disease Network

Interactive Features

Quiz
Terminal Ileal Resection and CRC Risk
08/07/2025
Rebecca Mashaw
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in patients with Crohn’s disease associated with colorectal cancer risk? See what recent research found by taking our quiz.
Is terminal ileum resection in...
08/07/2025
Gastroenterology
Quiz
Does Hormone Replacement Therapy Affect IBD?
07/18/2025
Can hormone replacement therapy help or harm disease activity among women with IBD? Our quiz will show the answer!
Can hormone replacement therapy help or harm disease activity among women with IBD? Our quiz will show the answer!
Can hormone replacement therapy...
07/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Can Perspiration Reveal IBD Biomarkers?
07/18/2025
Can a wearable sensor help monitor disease activity in IBD--via sweat? Take our quiz to get the answer.
Can a wearable sensor help monitor disease activity in IBD--via sweat? Take our quiz to get the answer.
Can a wearable sensor help...
07/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Making EHRs Work
07/01/2025
Rebecca Mashaw
Which of the following factors did clinicians say in a recent study is particularly important for EHR functionality in the context of IBD?
Which of the following factors did clinicians say in a recent study is particularly important for EHR functionality in the context of IBD?
Which of the following factors...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Do EHRs Help or Hinder in IBD Care?
07/01/2025
Rebecca Mashaw
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
According to a recent survey of clinicians who care for patients with inflammatory bowel disease, what percentage reported that their EHR system does not enhance patient care in IBD?
According to a recent survey of...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Advanced Combination Treatment for Refractory IBD
07/01/2025
Rebecca Mashaw
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
A multicenter Canadian study to evaluate advanced combination treatment (ACT) in patients with refractory inflammatory bowel disease (IBD) arrived at which of the following conclusions?
A multicenter Canadian study to...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Biomarkers in Perspiration
07/01/2025
A recent study evaluated the use of a wearable sensor to measure inflammatory biomarkers in perspiration as a noninvasive method for monitoring IBD activity. What did it show? Take our quiz to see if you know the answer!
A recent study evaluated the use of a wearable sensor to measure inflammatory biomarkers in perspiration as a noninvasive method for monitoring IBD activity. What did it show? Take our quiz to see if you know the answer!
A recent study evaluated the use...
07/01/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Hormone Replacement Impact on IBD
05/22/2025
Rebecca Mashaw
Does hormone replacement therapy have any effect on treatment for IBD among postmenopausal women? Take our quiz to find out!
Does hormone replacement therapy have any effect on treatment for IBD among postmenopausal women? Take our quiz to find out!
Does hormone replacement therapy...
05/22/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Upper GI Crohn's Disease
03/18/2025
Rebecca Mashaw
How much do you know about upper GI Crohn's disease? Take our quiz to check your knowledge!
How much do you know about upper GI Crohn's disease? Take our quiz to check your knowledge!
How much do you know about upper...
03/18/2025
Advances in Inflammatory Bowel Disease Network
Quiz
Preoperative Nutrition for Crohn’s Disease Patients
03/18/2025
Rebecca Mashaw
What is one benefit of preoperative exclusive enteral nutrition for Crohn’s disease patients? Take our quiz to find out if you know the answer!
What is one benefit of preoperative exclusive enteral nutrition for Crohn’s disease patients? Take our quiz to find out if you know the answer!
What is one benefit of...
03/18/2025
Advances in Inflammatory Bowel Disease Network

Expert Insights

IBD Drive time logo
Expert Insights
IBD Drive Time: Adam Faye, MD, on Managing IBD in Special Populations
11/03/2026
Raymond Cross, MD; Adam Faye, MD, MS
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Drs Adam Faye and Raymond Cross...
11/03/2026
Advances in Inflammatory Bowel Disease Network
David Schwartz
Conference Coverage
David Schwartz, MD, on Perianal Crohn's Disease
10/28/2026
David A. Schwartz
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his presentation on the evaluation and management of perianal fistulizing Crohn's disease from the ACG Scientific Meeting, including review of results from studies of guselkumab, upadacitinib, and vedolizumab as...
Dr Schwartz discusses his...
10/28/2026
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Positioning Therapies and Improving Outcomes in Ulcerative Colitis
10/23/2026
David T. Rubin, MD
Dr Rubin presents the key takeaways from his lecture on positioning therapies for ulcerative colitis to optimize outcomes, which he delivered at the ACG Postgraduate Course in Nashville. 
Dr Rubin presents the key takeaways from his lecture on positioning therapies for ulcerative colitis to optimize outcomes, which he delivered at the ACG Postgraduate Course in Nashville. 
Dr Rubin presents the key...
10/23/2026
Advances in Inflammatory Bowel Disease Network
Nayantara Coelho-Prabhu
Conference Coverage
Nayantara Coelho-Prabhu, MD, on Dysplasia Detection in IBD and PSC-IBD
10/15/2026
Nayantara Coelho-Prabhu, MD
Dr Coelho-Prabhu reviews the timing and techiques for surveillance of patients with inflammatory bowel disease for signs of colorectal cancer--and especially those with IBD and primary sclerosing cholangitis, which places them among those...
Dr Coelho-Prabhu reviews the timing and techiques for surveillance of patients with inflammatory bowel disease for signs of colorectal cancer--and especially those with IBD and primary sclerosing cholangitis, which places them among those...
Dr Coelho-Prabhu reviews the...
10/15/2026
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Histologic Outcomes of QUASAR Extension Study
10/13/2026
David T. Rubin, MD
Dr Rubin reviews data from the QUASAR phase 3 trial of guselkumab in patients with ulcerative colitis, specifically looking at histologic remission, which he presented at the ACG Scientific Meeting in Nashville.
Dr Rubin reviews data from the QUASAR phase 3 trial of guselkumab in patients with ulcerative colitis, specifically looking at histologic remission, which he presented at the ACG Scientific Meeting in Nashville.
Dr Rubin reviews data from the...
10/13/2026
Advances in Inflammatory Bowel Disease Network
Ray Cross
Conference Coverage
Raymond Cross, MD, on Fibrostenotic Crohn's Disease
10/11/2026
Raymond Cross, MD
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Dr Cross reviews his presentation at the ACG Postgraduate Course on the diagnosis and management of fibrostenotic strictures in Crohn's disease, including options for medical, endoscopic, and surgical treatment.
Dr Cross reviews his...
10/11/2026
Advances in Inflammatory Bowel Disease Network
Conference Coverage
Early Surgery or IL-23 for Crohn's Disease? Drs Corey Siegel and Gil Melmed Discuss Patient Survey Results
10/11/2026
Corey A. Siegel, MD, MS; Gil Y. Melmed, MD
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed discuss results of a survey of patients with ileocolic Crohn's disease that revealed roughly equal numbers would participate in a patient preference design study in which they could choose whether to receive...
Drs Corey Siegel and Gil Melmed...
10/11/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Sara Horst, MD, on Physician Burnout
09/28/2026
Raymond Cross, MD; Sara Horst, MD
Hosts Raymond Cross, MD, and Sara Horst, MD, have a frank discussion about the extent of burnout among physicians—including gastroenterologists—including causes, and advice on how to better manage time and work-life balance.
Hosts Raymond Cross, MD, and Sara Horst, MD, have a frank discussion about the extent of burnout among physicians—including gastroenterologists—including causes, and advice on how to better manage time and work-life balance.
Hosts Raymond Cross, MD, and...
09/28/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Rebecca Brown, MD, on Controversies in IBD Surgery
09/15/2026
Raymond Cross, MD; Rebecca Brown, MD
Host Raymond Cross, MD, and colorectal surgeon Rebecca Brown, MD, discuss surgical therapies for Crohn's disease and ulcerative colitis, including controversies about the best approaches.
Host Raymond Cross, MD, and colorectal surgeon Rebecca Brown, MD, discuss surgical therapies for Crohn's disease and ulcerative colitis, including controversies about the best approaches.
Host Raymond Cross, MD, and...
09/15/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Gursimran Kocchar, MD, on Medical and Endoscopic Management of Strictures in Crohn's Disease
08/28/2026
Raymond Cross, MD; Gursimran S. Kochhar
Host Raymond Cross, MD, brings in Dr Gursiman Kocchar to share his expertise in the management of strictures in Crohn's disease, from medical therapies to endoscopic procedures to surgery.
Host Raymond Cross, MD, brings in Dr Gursiman Kocchar to share his expertise in the management of strictures in Crohn's disease, from medical therapies to endoscopic procedures to surgery.
Host Raymond Cross, MD, brings...
08/28/2026
Advances in Inflammatory Bowel Disease Network

Conference Coverage

Research Highlights
Guselkumab Dose Escalation Shows Sustained Benefit in Crohn’s Disease
05/13/2026
Rebecca Mashaw
GALAXI 2 and 3 extension data suggest that escalating guselkumab maintenance dosing may safely improve clinical and endoscopic outcomes in Crohn’s disease patients with inadequate response.
GALAXI 2 and 3 extension data suggest that escalating guselkumab maintenance dosing may safely improve clinical and endoscopic outcomes in Crohn’s disease patients with inadequate response.
GALAXI 2 and 3 extension data...
05/13/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
PROFILE Study Confirms Early “Top-Down” Therapy Reduces Long-Term Complications in Crohn’s Disease
05/13/2026
Jessica Garlewicz
Disease progression was more common in the cohort on step-up therapy, with higher rates of stricturing and penetrating complications and hospitalizations.
Disease progression was more common in the cohort on step-up therapy, with higher rates of stricturing and penetrating complications and hospitalizations.
Disease progression was more...
05/13/2026
Advances in Inflammatory Bowel Disease Network
Expert Insights
Corey Siegel, MD, and Adam Cheifetz, MD, on 'Flipping the Script' in IBD
05/12/2026
Corey A. Siegel, MD, MS; Adam S. Cheifetz, MD
Drs Cheifetz and Siegel discuss an abstract presented at DDW on the value of "flipping the script" from traditional step-up therapy for IBD to using advanced therapy for virtually all Crohn's disease and ulcerative colitis patients.
Drs Cheifetz and Siegel discuss an abstract presented at DDW on the value of "flipping the script" from traditional step-up therapy for IBD to using advanced therapy for virtually all Crohn's disease and ulcerative colitis patients.
Drs Cheifetz and Siegel discuss...
05/12/2026
Advances in Inflammatory Bowel Disease Network
Research Review
FUZION Trial Shows Guselkumab Improves Fistula Remission in Perianal Crohn’s Disease
05/08/2026
Jessica Garlewicz
FUZION is the first and only randomized, controlled trial to show efficacy of an IL-23p19 antagonist in perianal fistulizing Crohn’s disease and the first trial of any therapy for perianal Crohn's disease since 1999.
FUZION is the first and only randomized, controlled trial to show efficacy of an IL-23p19 antagonist in perianal fistulizing Crohn’s disease and the first trial of any therapy for perianal Crohn's disease since 1999.
FUZION is the first and only...
05/08/2026
Advances in Inflammatory Bowel Disease Network
Research Review
Mirikizumab Shows Progressive Histologic Improvement in Ulcerative Colitis, With Strong Rectal Response
05/06/2026
Jessica Garlewicz
The study uniquely focused on patients with baseline bowel urgency, integrating symptom burden with objective mucosal healing endpoints.
The study uniquely focused on patients with baseline bowel urgency, integrating symptom burden with objective mucosal healing endpoints.
The study uniquely focused on...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
Active IBD and Steroid Use Linked to Higher RSV Risk
05/06/2026
Jessica Garlewicz
Among vaccinated patients with active IBD, RSV infection rates were no longer significantly different compared with those with nonactive disease.
Among vaccinated patients with active IBD, RSV infection rates were no longer significantly different compared with those with nonactive disease.
Among vaccinated patients with...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Research Highlights
Early Endoscopic and Histologic Response With Guselkumab Predicts Long-Term Remission in UC
05/06/2026
Jessica Garlewicz
Endoscopic and histologic improvements early in treatment appear to serve as reliable indicators of sustained remission without corticosteroids.
Endoscopic and histologic improvements early in treatment appear to serve as reliable indicators of sustained remission without corticosteroids.
Endoscopic and histologic...
05/06/2026
Advances in Inflammatory Bowel Disease Network
Best of 2025
From the AIBD Open Air Studio
Best of 2025 in IBD: Expert Roundtable from Advances in IBD
12/18/2025
Marla C. Dubinsky, MD; Parambir Dulai, MD; Bruce E. Sands, MD, MS
Drs Marla Dubinsky, Bruce Sands, and Parambir Dulai inaugurated the Open Air Studio at the Advances in IBD 2025 annual meeting with a review of the best research and most promising advances in the treatment of inflammatory bowel disease...
Drs Marla Dubinsky, Bruce Sands, and Parambir Dulai inaugurated the Open Air Studio at the Advances in IBD 2025 annual meeting with a review of the best research and most promising advances in the treatment of inflammatory bowel disease...
Drs Marla Dubinsky, Bruce Sands,...
12/18/2025
Advances in Inflammatory Bowel Disease Network
Phillip Fleshner
Conference Coverage
Phillip Fleshner, MD, on the Top Things Surgeons Want Gastroenterologists to Know
12/18/2025
Rebecca Mashaw
In his address to the Advances in IBD annual meeting, Dr Phillip Fleshner stressed the importance of early involvement of the surgeon in collaborative patient care and that the need for surgery should not be viewed as a failure of medical...
In his address to the Advances in IBD annual meeting, Dr Phillip Fleshner stressed the importance of early involvement of the surgeon in collaborative patient care and that the need for surgery should not be viewed as a failure of medical...
In his address to the Advances...
12/18/2025
Advances in Inflammatory Bowel Disease Network
Ray Cross
Conference Coverage
Raymond Cross, MD, on Risk Stratification and Individualized Treatment Selection in Evolving IBD Management
12/17/2025
Jessica Garlewicz
Dr Raymond Cross emphasized the importance of identifying risk early and aligning therapy with both clinical severity and patient-specific needs as IBD moves toward precision medicine.
Dr Raymond Cross emphasized the importance of identifying risk early and aligning therapy with both clinical severity and patient-specific needs as IBD moves toward precision medicine.
Dr Raymond Cross emphasized the...
12/17/2025
Advances in Inflammatory Bowel Disease Network

About Us

The Advances in Inflammatory Bowel Disease Network provides gastroenterology professionals with a central source for the wealth of content on IBD—articles, abstracts, videos, podcasts, and commentary—generated at our regional and annual meetings.

Learn more about our event and register here:

AIBD logo

Latest Podcasts

IBD Drive time logo
Expert Insights
IBD Drive Time: Adam Faye, MD, on Managing IBD in Special Populations
11/03/2026
Raymond Cross, MD; Adam Faye, MD, MS
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Drs Adam Faye and Raymond Cross discuss the particular issues to consider when treating patients who are older, obese, or frail, as well as patients with a history of or current cancer or heart disease.
Drs Adam Faye and Raymond Cross...
11/03/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Sara Horst, MD, on Physician Burnout
09/28/2026
Raymond Cross, MD; Sara Horst, MD
Hosts Raymond Cross, MD, and Sara Horst, MD, have a frank discussion about the extent of burnout among physicians—including gastroenterologists—including causes, and advice on how to better manage time and work-life balance.
Hosts Raymond Cross, MD, and Sara Horst, MD, have a frank discussion about the extent of burnout among physicians—including gastroenterologists—including causes, and advice on how to better manage time and work-life balance.
Hosts Raymond Cross, MD, and...
09/28/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Rebecca Brown, MD, on Controversies in IBD Surgery
09/15/2026
Raymond Cross, MD; Rebecca Brown, MD
Host Raymond Cross, MD, and colorectal surgeon Rebecca Brown, MD, discuss surgical therapies for Crohn's disease and ulcerative colitis, including controversies about the best approaches.
Host Raymond Cross, MD, and colorectal surgeon Rebecca Brown, MD, discuss surgical therapies for Crohn's disease and ulcerative colitis, including controversies about the best approaches.
Host Raymond Cross, MD, and...
09/15/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Gursimran Kocchar, MD, on Medical and Endoscopic Management of Strictures in Crohn's Disease
08/28/2026
Raymond Cross, MD; Gursimran S. Kochhar
Host Raymond Cross, MD, brings in Dr Gursiman Kocchar to share his expertise in the management of strictures in Crohn's disease, from medical therapies to endoscopic procedures to surgery.
Host Raymond Cross, MD, brings in Dr Gursiman Kocchar to share his expertise in the management of strictures in Crohn's disease, from medical therapies to endoscopic procedures to surgery.
Host Raymond Cross, MD, brings...
08/28/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
Marla Dubinsky, MD, on Lifelong Reproductive Care for Women With IBD
08/05/2026
Raymond Cross, MD; Marla C. Dubinsky, MD
Dr Marla Dubinsky joins host Raymond Cross, MD, for a discussion about how inflammatory bowel disease affects women's reproductive health beyond childbearing, from choosing contraception and using hormonal replacement therapy in perimenopause.
Dr Marla Dubinsky joins host Raymond Cross, MD, for a discussion about how inflammatory bowel disease affects women's reproductive health beyond childbearing, from choosing contraception and using hormonal replacement therapy in perimenopause.
Dr Marla Dubinsky joins host...
08/05/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Dana Lukin, MD, on Ulcerative Proctitis
07/07/2026
Raymond Cross, MD; Dana Lukin, MD
Drs Raymond Cross and Dana Lukin review isolated ulcerative proctitis, including risk factors, diagnosis, mimics, and cancer surveillance.
Drs Raymond Cross and Dana Lukin review isolated ulcerative proctitis, including risk factors, diagnosis, mimics, and cancer surveillance.
Drs Raymond Cross and Dana Lukin...
07/07/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jennifer Seminerio, MD, on Advanced Combination Therapy
06/12/2026
Raymond Cross, MD; Jennifer Seminerio, MD
Drs Cross and Seminerio discuss advanced combination therapy, which involves use of more than one biologic or a biologic and an advanced small molecule, including trial results to date, types of combinations, safety considerations, and which...
Drs Cross and Seminerio discuss advanced combination therapy, which involves use of more than one biologic or a biologic and an advanced small molecule, including trial results to date, types of combinations, safety considerations, and which...
Drs Cross and Seminerio discuss...
06/12/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jordan Axelrad, MD, on Communicating Risks to Patients With IBD
05/22/2026
Raymond Cross, MD; Jordan Axelrad, MD
Drs Raymond Cross and Jordan Axelrad provide guidance to clinicians about the best ways to put risks—both of uncontrolled IBD and of therapies—into perspective for patients.
Drs Raymond Cross and Jordan Axelrad provide guidance to clinicians about the best ways to put risks—both of uncontrolled IBD and of therapies—into perspective for patients.
Drs Raymond Cross and Jordan...
05/22/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Colleen Kelly, MD, on Obesity and IBD
04/20/2026
Raymond Cross, MD; Colleen Kelly, MD
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on Dr Colleen Kelly to discuss the increasing prevalence of obesity among patients with IBD, how obesity can complicate Crohn's disease and ulcerative colitis, and the role of GLP-1 RAs and bariatric surgery in...
Host Raymond Cross, MD, calls on...
04/20/2026
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Expert Insights
IBD Drive Time: Jared Magee, MD, on Men's Health in IBD
04/07/2026
Raymond Cross, MD; Jared Magee, MD
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared Magee discuss some of the special concerns that affect men with inflammatory bowel disease, from cardiac concerns to sexual dysfunction and assessing for anal cancer.
Drs Raymond Cross and Jared...
04/07/2026
Advances in Inflammatory Bowel Disease Network

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use